Patrick Thomas Ellinor II
Director · Editas Medicine, Inc.
Individual
- 2026
- Aug 7, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Patrick Thomas Ellinor II files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Gilmore Neil O'Neill - $80K in EDIT purchases and sales in the last 12 months
- Linda Burkly - $19K in EDIT purchases and sales in the last 12 months
- Amy Parison - $6K in EDIT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Patrick Thomas Ellinor II?
Patrick Thomas Ellinor II is a corporate insider, tracked as Director of Editas Medicine, Inc. (EDIT). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Patrick Thomas Ellinor II submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.